85 related articles for article (PubMed ID: 38512975)
1. MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylation.
Betancor G; Jimenez-Guardeño JM; Lynham S; Antrobus R; Khan H; Sobala A; Dicks MDJ; Malim MH
Nat Microbiol; 2021 Aug; 6(8):1031-1042. PubMed ID: 34282309
[TBL] [Abstract][Full Text] [Related]
2. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
3. The SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis.
Guo H; Yang W; Li H; Yang J; Huang Y; Tang Y; Wang S; Ni F; Yang W; Yu X-F; Wei W
mBio; 2024 Jun; ():e0136324. PubMed ID: 38888311
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation.
Hilbig K; Towers R; Schmitz M; Bornhäuser M; Lennig P; Zhang Y
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930843
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal binding of cyclophilin A and CPSF6 to capsid regulates HIV-1 nuclear entry and integration.
Ingram Z; Kline C; Hughson AK; Singh PK; Fischer HL; Sowd GA; Watkins SC; Kane M; Engelman AN; Ambrose Z
bioRxiv; 2024 Apr; ():. PubMed ID: 38645162
[TBL] [Abstract][Full Text] [Related]
6. Capsid-dependent lentiviral restrictions.
Twentyman J; Emerman M; Ohainle M
J Virol; 2024 Apr; 98(4):e0030824. PubMed ID: 38497663
[TBL] [Abstract][Full Text] [Related]
7. Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.
Staeheli P; Haller O
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258007
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus.
Padron A; Prakash P; Pandhare J; Luban J; Aiken C; Balasubramaniam M; Dash C
J Virol; 2023 Nov; 97(11):e0073223. PubMed ID: 37843371
[TBL] [Abstract][Full Text] [Related]
9. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975
[TBL] [Abstract][Full Text] [Related]
10. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
bioRxiv; 2023 Nov; ():. PubMed ID: 38014352
[TBL] [Abstract][Full Text] [Related]
11. Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2.
Kane M; Rebensburg SV; Takata MA; Zang TM; Yamashita M; Kvaratskhelia M; Bieniasz PD
Elife; 2018 Aug; 7():. PubMed ID: 30084827
[TBL] [Abstract][Full Text] [Related]
12. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
13. GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.
Xie L; Ju Z; Zhong C; Wu Y; Zan Y; Hou W; Feng Y
Virol Sin; 2021 Feb; 36(1):85-94. PubMed ID: 32632818
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
[TBL] [Abstract][Full Text] [Related]
15. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
Twentyman J; Khalifeh A; Felton AL; Emerman M; Ohainle M
Retrovirology; 2023 Aug; 20(1):15. PubMed ID: 37608289
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
